PhDr. Karel Hejduk
Researcher, Institute of Biostatistics and Analyses
Correspondence Address:
Kamenice 753/5, 625 00 Brno
Office: 354
Poštovská 68/3
602 00 Brno
Phone: | +420 549 49 7246 |
---|---|
E‑mail: |
Total number of publications: 202
2013
-
Zpráva z „malých“ registrů – Pemetrexed, Tarceva a Yondelis
Klinická onkologie, year: 2013, volume: 26, edition: 1
2012
-
ATTRA - clinical registry for monitoring effectiveness and safety of biological therapies for rheumatic diseases in Czech Republic: more than 10-years experience
Year: 2012, type: Appeared in Conference without Proceedings
-
Bevacizumab u karcinomu prsu - zhodnocení údajů českého klinického registru BREAST
Year: 2012, type: Conference abstract
-
Dostupnost "centrově" pneumoonkologické léčby pokročilého nemalobuněčného karcinomu plic (NSCLC) ihned po stanovení diagnózy. Jak je na tom Česká republika?
Year: 2012, type: Conference abstract
-
Efficacy of the first and subsequent courses of anti-TNF therapy in patients with ankylosing spondylitis – results from the Czech National Register ATTRA
Reumatologia, year: 2012, volume: 50, edition: 4
-
Erlotinib treatment results in patients with advanced non-small-cell lung cancer (NSCLC)—Influence of clinical predictors
Year: 2012, type: Conference abstract
-
Group of patients with NSCLC treated with erlotinib in the Czech Republic longer than 12 months
Year: 2012, type: Conference abstract
-
Histologický registr karcinomu prsu - MAGISTER - jaké poznatky přinesl první rok fungování?
Breast cancer news, year: 2012, volume: Duben 2012, edition: 2
-
Characteristics of advanced NSCLC patients with at least 6 months erlotinib treatment duration in Czech Republic
Year: 2012, type: Conference abstract
-
Klinický registr BREAST
Klinická onkologie, year: 2012, volume: 25, edition: 3